Description of outcome and adverse events in 21 cats with locally advanced nasal planum squamous cell carcinoma treated with electrochemotherapy.

Elena Ferrer-Jorda, Ignacio Rodríguez-Pizà
Author Information
  1. Elena Ferrer-Jorda: AniCura Glòries Hospital Veterinari, Barcelona, Spain. ORCID
  2. Ignacio Rodríguez-Pizà: AniCura Glòries Hospital Veterinari, Barcelona, Spain.

Abstract

OBJECTIVES: Squamous cell carcinoma (SCC) is the most common tumour in the nasal planum of cats. Surgery has traditionally been the treatment of choice but might not be feasible in locally advanced scenarios. Electrochemotherapy (ECT) has shown good control in superficial tumours, but there is a lack of robust information about efficacy in locally advanced cases. The aim of this study was to assess the safety and efficacy of ECT in the treatment of locally advanced stage nasal planum SCC in cats.
METHODS: The clinical database of a veterinary referral hospital was searched retrospectively for cats diagnosed with a locally advanced nasal planum SCC (TNM or TNM) that had received ECT. Local response, adverse events and outcome were documented. The data were evaluated by inferential statistics and correlations between response, recurrence, feline immunodeficiency virus/feline leukaemia virus status, number of treatments, voltage and severity of adverse events, with Kaplan-Meier curves and log-rank tests. Statistical significance was set at <0.05.
RESULTS: In total, 21 cats were enrolled over a 4-year period. Nineteen cats achieved a complete response (CR) and two cats a partial response (PR) for an overall response rate of 100%. Cats achieving a CR had a median disease-free interval of 182 days (range 128-327) and those with a PR had a median progression-free survival of 156.5 days (range 122-191). The median time to progression was not reached. The overall survival was 453 days for a median follow-up of 341 days (range 191-989). Of the cats, 62% had grade 3 or 4 toxicities, but no deaths due to the treatment were documented. Only voltage was correlated with longer survival ( = 0.001).
CONCLUSIONS AND RELEVANCE: ECT appears to be an effective treatment for feline nasal planum SCC and could be considered a first-line therapy for locally advanced cases. Toxicities reported can be severe in the short term and these could be secondary to more invasive lesions and equipment used.

Keywords

References

  1. J Feline Med Surg. 2013 May;15(5):401-7 [PMID: 23603503]
  2. Cancer Drug Resist. 2022 Jun 21;5(3):595-611 [PMID: 36176753]
  3. J Am Anim Hosp Assoc. 1997 Jul-Aug;33(4):329-32 [PMID: 9204469]
  4. Clin Tech Small Anim Pract. 2007 May;22(2):42-5 [PMID: 17591288]
  5. Anticancer Res. 2020 Nov;40(11):6485-6492 [PMID: 33109587]
  6. J Natl Cancer Inst. 1971 May;46(5):1073-8 [PMID: 5157843]
  7. Vet Sci. 2021 Mar 22;8(3): [PMID: 33809822]
  8. Vet J. 2009 Jan;179(1):117-20 [PMID: 17904882]
  9. J Feline Med Surg. 2014 Apr;16(4):291-9 [PMID: 24127456]
  10. J Vet Intern Med. 2015 Sep-Oct;29(5):1368-75 [PMID: 26192904]
  11. Technol Cancer Res Treat. 2018 Jan 1;17:1533033818785329 [PMID: 29986632]
  12. Front Vet Sci. 2020 Sep 29;7:575911 [PMID: 33134356]
  13. Curr Cancer Drug Targets. 2016;16(1):43-52 [PMID: 26712353]

MeSH Term

Animals
Cats
Cat Diseases
Electrochemotherapy
Carcinoma, Squamous Cell
Male
Retrospective Studies
Female
Nose Neoplasms
Treatment Outcome

Word Cloud

Created with Highcharts 10.0.0catsplanumlocallyadvancednasalresponseSCCtreatmentECTmediandayscarcinomaadverseeventsrangesurvivalcellefficacycasesTNMoutcomedocumentedfelinevoltage21CRPRoverallelectrochemotherapyOBJECTIVES:SquamouscommontumourSurgerytraditionallychoicemightfeasiblescenariosElectrochemotherapyshowngoodcontrolsuperficialtumourslackrobustinformationaimstudyassesssafetystageMETHODS:clinicaldatabaseveterinaryreferralhospitalsearchedretrospectivelydiagnosedreceivedLocaldataevaluatedinferentialstatisticscorrelationsrecurrenceimmunodeficiencyvirus/felineleukaemiavirusstatusnumbertreatmentsseverityKaplan-Meiercurveslog-ranktestsStatisticalsignificanceset<005RESULTS:totalenrolled4-yearperiodNineteenachievedcompletetwopartialrate100%Catsachievingdisease-freeinterval182128-327progression-free1565122-191timeprogressionreached453follow-up341191-98962%grade34toxicitiesdeathsduecorrelatedlonger = 0001CONCLUSIONSANDRELEVANCE:appearseffectiveconsideredfirst-linetherapyToxicitiesreportedcansevereshorttermsecondaryinvasivelesionsequipmentusedDescriptionsquamoustreatedNasalbleomycinelectroporationhead

Similar Articles

Cited By